Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study

BACKGROUND: Patients with impaired liver function (ILF) were excluded from clinical trials that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in patients with atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of NOACs in atri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun‐Li, Wu, Victor Chien‐Chia, Kuo, Chang‐Fu, Chu, Pao‐Hsien, Tseng, Hsiao‐Jung, Wen, Ming‐Shien, Chang, Shang‐Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201449/
https://www.ncbi.nlm.nih.gov/pubmed/30371232
http://dx.doi.org/10.1161/JAHA.118.009263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201449/
https://www.ncbi.nlm.nih.gov/pubmed/30371232
http://dx.doi.org/10.1161/JAHA.118.009263

Ejemplares similares